Uni-Logo
Sie sind hier: Startseite Molekulare Medizin und Zellforschung AG Maurer Veröffentlichungen
Artikelaktionen

Veröffentlichungen

2017 Schlicher L, Brauns-Schubert P, Schubert F, Maurer U. SPATA2: more than a missing link. Cell Death Differ. 2017 Jul;24(7):1142-1147. doi: 10.1038/cdd.2017.26. Epub 2017 Mar 10. Pubmed28282038
  Schlicher L, Maurer U. SPATA2: new insights in the assembly of the TNFR signaling complex. Cell Cycle.2017 Jan 2;16(1):11-12. doi: 10.1080/15384101.2016.1232090. Epub 2016 Sep 16. Pubmed27635695
2016 Schlicher L, Wissler M, Preiss F, Brauns-Schubert P, Jakob C, Dumit V, Borner C, Dengjel J, Maurer U. SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death. EMBO Rep. 2016 Oct;17(10):1485-1497. Epub 2016 Jul 25. Pubmed27458237
Peintner L, Novelli F, Smirnov A, Maurer U, Borner C, von Karstedt S. 9th Tuscany Retreat on Cancer Research: genetic profiling, resistance mechanisms and novel treatment concepts in cancer. Cell Death Differ. 2016 Jan;23(1):183-4. doi: 10.1038/cdd.2015.148. Epub 2015 Nov 13. Pubmed26564399
2015 Neumann S, Maadidi SE, Faletti L, Haun F, Labib S, Schejtman A, Maurer U, Borner C. How do viruses control mitochondria-mediated apoptosis? Virus Res. 2015 Nov 2;209:45-55. doi: 10.1016/j.virusres.2015.02.026. Epub 2015 Mar 1Pubmed25736565
  Papaianni E, El Maadidi S, Schejtman A, Neumann S, Maurer U, Marino-Merlo F, Mastino A, Borner C. Phylogenetically Distant Viruses Use the Same BH3-Only Protein Puma to Trigger Bax/Bak-Dependent Apoptosis of Infected Mouse and Human Cells. PLoS One. 2015 Jun 1;10(6):e0126645. doi: 10.1371/journal.pone.0126645. eCollection 2015. Pubmed26030884
2014 Lindner SE, Wissler M, Gründer A, Aumann K, Ottina E, Peintner L, Brauns-Schubert P, Preiss F, Herzog S, Borner C, Charvet C, Villunger A, Pahl HL, Maurer U. Increased leukocyte survival and accelerated onset of lymphoma in the absence of MCL-1 S159-phosphorylation.
Oncogene. 2014 Oct 30;33(44):5221-4. doi: 10.1038/onc.2013.469. Epub 2013 Nov 11. Pubmed24213575
Maurer U, Preiss F, Brauns-Schubert P, Schlicher L, Charvet C.
GSK-3 - at the crossroads of cell death and survival. J Cell Sci. 2014 Apr 1;127(Pt 7):1369-78. doi: 10.1242/jcs.138057. Pubmed24687186
El Maadidi S, Faletti L, Berg B, Wenzl C, Wieland K, Chen ZJ, Maurer U, Borner C. A novel mitochondrial MAVS/Caspase-8 platform links RNA virus-induced innate antiviral signaling to Bax/Bak-independent apoptosis. J Immunol. 2014 Feb 1;192(3):1171-83. doi: 10.4049/jimmunol.1300842. Epub 2014 Jan 3. Pubmed24391214
2013 Geissler A, Haun F, Frank DO, Wieland K, Simon MM, Idzko M, Davis RJ, Maurer U, Borner C. Apoptosis induced by the fungal pathogen gliotoxin requires a triple phosphorylation of Bim by JNK. Cell Death Differ. 2013 Oct;20(10):1317-29. doi: 10.1038/cdd.2013.78. Epub 2013 Jul 5. Pubmed23832115
2012 Vogel S, Raulf N, Bregenhorn S, Biniossek ML, Maurer U, Czabotar P, Borner C. Cytosolic Bax: Does it require binding proteins to keep its pro-apoptotic activity in check? J Biol Chem. 2012 Mar 16;287(12):9112-27. Epub 2012 Jan 25. Pubmed22277657
2011 Charvet C, Maurer U. Cell Cycle. GSK-3 turns p53 deadly. 2011 Nov 1;10(21):3621-2. Pubmed22033176
  Charvet C, Wissler M, Brauns-Schubert P, Wang SJ, Tang Y, Sigloch FC, Mellert H, Brandenburg M, Lindner SE, Breit B, Green DR, McMahon SB, Borner C, Gu W, Maurer U. Phosphorylation of Tip60 by GSK-3 Determines the Induction of PUMA and Apoptosis by p53. Mol Cell. 2011 Jun 10;42(5):584-96. Pubmed21658600
2009 Baudot AD, Jeandel PY, Mouska X, Maurer U, Tartare-Deckert S, Raynaud SD, Cassuto JP, Ticchioni M, Deckert M. The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression. Oncogene. 2009 Sep 17;28(37):3261-73. Epub 2009 Jul 6. Pubmed19581935
2008 Walter D, Schmich K, Vogel S, Pick R, Kaufmann T, Hochmuth FC, Haber A, Neubert K, McNelly S, von Weizsäcker F, Merfort I, Maurer U, Strasser A, Borner C. Switch from type II to I Fas/CD95 death signaling on in vitro culturing of primary hepatocytes. Hepatology. 2008 Dec;48(6):1942-53. Pubmed19003879
2007 Colell A, Ricci JE, Tait S, Milasta S, Maurer U, Bouchier-Hayes L,
Fitzgerald P, Guio-Carrion A, Waterhouse NJ, Li CW, Mari B, Barbry P,
Newmeyer DD, Beere HM, Green DR. GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. Cell. 2007 Jun 1;129(5):983-97, Pubmed17540177
2006 Charvet C, Canonigo AJ, Becart S, Maurer U, Miletic AV, Swat W, Deckert M, Altman A: Vav1 promotes T cell cycle progression by linking TCR/CD28 costimulation to FOXO1 and p27kip1 expression. J Immunol. 2006 Oct 15;177(8):5024-31, Pubmed17015685
  Maurer U, Spierings DCJ, McStay G, Bender C, Saleh M, Chipuk J, Green DR:Mitochondrial Pathway of Apoptosis: Antiapoptotic Bcl-2 Family Sci. STKE 2006 (Connections Map Pathway), Science
  Manoharan A, Kiefer T, Leist S, Schrader K, Urban C, Walter D, Maurer U, Borner C. Identification of a 'genuine' mammalian homolog of nematodal CED-4: is the hunt over or do we need better guns? Cell Death Differ 13, 877 – 1047, Pubmed16691212
  Maurer U, Charvet C, Wagman AS, Dejardin E, Green DR. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell. 2006 Mar 17;21(6):749-60. Pubmed16543145
2005 Spierings D, McStay G, Saleh M, Bender C, Chipuk J, Maurer U, Green DR. Connected to death: the (unexpurgated) mitochondrial pathway of apoptosis. Science. 2005 Oct 7;310(5745):66-7. Pubmed16210526
2004 Viatour P, Dejardin E, Warnier M, Lair F, Claudio E, Bureau F, Marine JC, Merville MP, Maurer U, Green D, Piette J, Siebenlist U, Bours V, Chariot A. GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity. Mol Cell. 2004 Oct 8;16(1):35-45. Pubmed15469820
2003 Chipuk JE, Maurer U, Green DR, Schuler M. Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription. Cancer Cell. 2003 Nov;4(5):371-81. Pubmed14667504
Schuler M, Maurer U, Goldstein JC, Breitenbucher F, Hoffarth S, Waterhouse NJ, Green DR. p53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation. Cell Death Differ. 2003 Apr;10(4):451-60. Pubmed12719722
  Hubinger G, Wehnes E, Xue L, Morris SW, Maurer U. Hammerhead ribozyme-mediated cleavage of the fusion transcript NPM-ALK associated with anaplastic large-cell lymphoma. Exp Hematol. 2003 Mar;31(3):226-33. Pubmed12644020
2002 Hubinger G, Schmid M, Linortner S, Manegold A, Bergmann L, Maurer U. Ribozyme-mediated cleavage of wt1 transcripts suppresses growth of leukemia cells. Exp Hematol. 2001 Oct;29(10):1226-35. Pubmed11602325
Bonzon C, Droin NM, Maurer U, Ricci JE. Death in paradise.Cell Death Differ. 2002 Jul;9(7):780-2. No abstract available. Pubmed12058283
  Karakas T, Miething CC, Maurer U, Weidmann E, Ackermann H, Hoelzer D, Bergmann L. The coexpression of the apoptosis-related genes bcl-2 and wt1 in predicting survival in adult acute myeloid leukemia. Leukemia. 2002 May;16(5):846-54. Pubmed11986946
2001 Graf J, Merk B, Maurer U, Muller E, Bergmann L. Identification of novel polymorphisms in intron 7 of the human p53 gene in acute myeloid leukemia and healthy donors. Leuk Lymphoma. 2001 May;41(5-6):655-8. Pubmed11378583
  Maurer U, Jehan F, Englert C, Hubinger G, Weidmann E, DeLuca HF, Bergmann L. The Wilms' tumor gene product (WT1) modulates the response to 1,25-dihydroxyvitamin D3 by induction of the vitamin D receptor.J Biol Chem. 2001 Feb 9;276(6):3727-32. Epub 2000 Oct 24. Pubmed11050081
2000 Greiner J, Ringhoffer M, Simikopinko O, Szmaragowska A, Huebsch S, Maurer U, Bergmann L, Schmitt M. Simultaneous expression of different immunogenic antigens in acute myeloid leukemia. Exp Hematol. 2000 Dec;28(12):1413-22. Pubmed11146163
1998 Karakas T, Maurer U, Weidmann E, Miething CC, Hoelzer D, Bergmann L.High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia. Ann Oncol. 1998 Feb;9(2):159-65. Pubmed9553660
1997 Maurer U, Weidmann E, Karakas T, Hoelzer D, Bergmann L. Wilms tumor gene (wt1) mRNA is equally expressed in blast cells from acute myeloid leukemia and normal CD34+ progenitors. Blood. 1997 Nov 15;90(10):4230-2. Pubmed9354696
  Maurer U, Brieger J, Weidmann E, Mitrou PS, Hoelzer D, Bergmann L. The Wilms' tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitro. Exp Hematol. 1997 Aug;25(9):945-50. Pubmed9257807
  Bergmann L, Miething C, Maurer U, Brieger J, Karakas T, Weidmann E, Hoelzer D. High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome.Blood. 1997 Aug 1;90(3):1217-25. Pubmed9242555
  Bergmann L, Maurer U, Weidmann E. Wilms tumor gene expression in acute myeloid leukemias.Leuk Lymphoma. 1997 May;25(5-6):435-43. Review. Pubmed9250813
  Weidmann E, Brieger J, Karakas T, Maurer U, Pascheberg U, Hoelzer D, Mitrou PS, Bergmann L. Establishment and characterization of a new, factor-independent acute myeloid leukemia line designated Ei501. Leukemia. 1997 May;11(5):709-13. Pubmed9180296
1995 Brieger J, Weidmann E, Maurer U, Hoelzer D, Mitrou PS, Bergmann L.The Wilms' tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCR. Ann Oncol. 1995 Oct;6(8):811-6. Pubmed8589020
   
   
« Oktober 2017 »
Oktober
MoDiMiDoFrSaSo
1
2345678
9101112131415
16171819202122
23242526272829
3031
Benutzerspezifische Werkzeuge